Targeting the P2Y13 Receptor Suppresses IL-33 and HMGB1 Release and Ameliorates Experimental Asthma. Werder RB, Ullah MA, Rahman MM, Simpson J, et al. Am J Respir Crit Care Med 2021 Dec 3. doi: 10.1164/rccm.202009-3686.

Read + Share

Amedeo Smart

Independent Medical Education

Werder RB, Ullah MA, Rahman MM, Simpson J, et al. Targeting the P2Y13 Receptor Suppresses IL-33 and HMGB1 Release and Ameliorates Experimental Asthma. Am J Respir Crit Care Med 2021 Dec 3. doi: 10.1164/rccm.202009-3686.
PMID: 34860143